Exclusive

Publication

Byline

Location

Aarti Drugs gains as PAT rises to Rs 37 cr in Q3; declares dividend of Re 1/sh

Mumbai, Jan. 30 -- Revenue from operations declined 6.44% to Rs 568.50 crore in third quarter of FY25 as compared with Rs 607.61 crore posted same period a year ago. Profit before tax shed 1.53% to R... Read More